Immediate Impact
46 standout
Citing Papers
The interaction of innate immune and adaptive immune system
2024 Standout
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Works of Nada Hamad being referenced
A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with B-Cell Malignancies
2021
A Phase 1, Open-Label Study of MGD013, a Bispecific DART® Molecule Binding PD-1 and LAG-3 in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Nada Hamad | 223 | 243 | 142 | 87 | 523 | |
| Riad El Fakih | 202 | 260 | 89 | 75 | 617 | |
| Kyung‐Nam Koh | 146 | 282 | 80 | 79 | 617 | |
| Ivan Moiseev | 162 | 263 | 76 | 101 | 474 | |
| Takayoshi Tachibana | 104 | 314 | 130 | 78 | 499 | |
| Bungo Saito | 156 | 199 | 78 | 45 | 463 | |
| Man Updesh Singh Sachdeva | 98 | 217 | 186 | 115 | 601 | |
| Cécile Borel | 167 | 264 | 100 | 48 | 567 | |
| Aarthi Shenoy | 186 | 322 | 102 | 41 | 638 | |
| Deepesh Lad | 149 | 246 | 196 | 129 | 582 | |
| Nathalie Aladjidi | 161 | 254 | 80 | 48 | 583 |
All Works
Login with ORCID to disown or claim papers
Loading papers...